Tyrosyl-DNA Phosphodiesterase I Processing of Topoisomerase II-DNA Covalent Complexes is Dependent on Etoposide Stabilization and Tyrosyl-DNA Phosphodiesterase I N-terminal Domain

Tyrosyl-DNA phosphodiesterase I (Tdp1) hydrolyzes 3'- and 5'-phosphodiester linked DNA-adducts, including Topoisomerase I- and II-DNA covalent complexes (Topo1cc and Topo2cc). Utilizing the model organism Saccharomyces cerevisiae, which only expresses Tdp1 and does not contain TDP2 orthologs or activity, we investigated the conditions under which Tdp1 processes Topo2(peptide)cc in cells and examined the role of the Tdp1 N-terminal domain in resolving Topo2(peptide)cc. We replaced the transcription activator PDR1 gene with the chimeric pdr1dbd-CYC8 transcription repressor in our strain, resulting in increased sensitivity to etoposide and doxorubicin but not to mitoxantrone. Using Tdp1 catalytic histidine mutants that induce substrate-dependent toxicity, we detected that Tdp1 selectively processes etoposide stabilized Topo2(peptide)cc. In contrast, Tdp1's processing of Topo1cc is drug independent. Moreover, we observed that the yeast SCAN1-like H432R mutant induces a more severe toxic phenotype when processing etoposide-Topo2(peptide)cc than Topo1cc with or without camptothecin. Extrapolating this observation to SCAN1 cerebellar neurons, we hypothesize that the contribution of Tdp1H493R processing of Topo2β(peptide)cc trapped by e.g., oxidative damaged nucleotides, is potentially more substantial towards cerebellar atrophy and compels further investigation. Nonetheless, the observed toxic phenotypes induced by Tdp1 mutants are recessive and suppressed by endogenous wild-type Tdp1 by lowering 5'Tdp1(mutant)cc. Moreover, Tdp1 cannot process etoposide-Topo2cc in cells without its N-terminal domain. This suggests that in cells Tdp1's N-terminal domain plays a critical role in regulating Tdp1 activity potentially by mediating recruitment to the DNA-adduct and/or facilitating accessibility to the phosphodiester linkage within a protein/peptide-DNA complex or stabilizing of the DNA strands related to damaged nucleotide-adducts.

Authors

Institutions

Publication Details

Journal
Journal of Molecular Biology
Published
2026-03-17
DOI
https://doi.org/10.1016/j.jmb.2026.169759
Primary Topic
Cancer therapeutics and mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tyrosyl-DNA Phosphodiesterase I Processing of Topoisomerase II-DNA Covalent Complexes is Dependent on Etoposide Stabilization and Tyrosyl-DNA Phosphodiesterase I N-terminal Domain

Isaac A. Segura, Robert CAM van Waardenburg, Leanna G. Bridges, Victoria M. Albertson et al.
Journal of Molecular Biology
Cancer therapeutics and mechanisms
article

Tyrosyl-DNA Phosphodiesterase I Processing of Topoisomerase II-DNA Covalent Complexes is Dependent on Etoposide Stabilization and Tyrosyl-DNA Phosphodiesterase I N-terminal Domain

Isaac A. Segura, Robert CAM van Waardenburg, Leanna G. Bridges, Victoria M. Albertson, Aasim M. Musani
article en

Abstract

Tyrosyl-DNA phosphodiesterase I (Tdp1) hydrolyzes 3'- and 5'-phosphodiester linked DNA-adducts, including Topoisomerase I- and II-DNA covalent complexes (Topo1cc and Topo2cc). Utilizing the model organism Saccharomyces cerevisiae, which only expresses Tdp1 and does not contain TDP2 orthologs or activity, we investigated the conditions under which Tdp1 processes Topo2(peptide)cc in cells and examined the role of the Tdp1 N-terminal domain in resolving Topo2(peptide)cc. We replaced the transcription activator PDR1 gene with the chimeric pdr1dbd-CYC8 transcription repressor in our strain, resulting in increased sensitivity to etoposide and doxorubicin but not to mitoxantrone. Using Tdp1 catalytic histidine mutants that induce substrate-dependent toxicity, we detected that Tdp1 selectively processes etoposide stabilized Topo2(peptide)cc. In contrast, Tdp1's processing of Topo1cc is drug independent. Moreover, we observed that the yeast SCAN1-like H432R mutant induces a more severe toxic phenotype when processing etoposide-Topo2(peptide)cc than Topo1cc with or without camptothecin. Extrapolating this observation to SCAN1 cerebellar neurons, we hypothesize that the contribution of Tdp1H493R processing of Topo2β(peptide)cc trapped by e.g., oxidative damaged nucleotides, is potentially more substantial towards cerebellar atrophy and compels further investigation. Nonetheless, the observed toxic phenotypes induced by Tdp1 mutants are recessive and suppressed by endogenous wild-type Tdp1 by lowering 5'Tdp1(mutant)cc. Moreover, Tdp1 cannot process etoposide-Topo2cc in cells without its N-terminal domain. This suggests that in cells Tdp1's N-terminal domain plays a critical role in regulating Tdp1 activity potentially by mediating recruitment to the DNA-adduct and/or facilitating accessibility to the phosphodiester linkage within a protein/peptide-DNA complex or stabilizing of the DNA strands related to damaged nucleotide-adducts.

Journal of Molecular BiologyVol. 438(11)
University of Alabama at Birmingham (US)
Openalex Percentile: Top 19%
Cancer therapeutics and mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.